Synapse - Martin Fleisher

Results (312)

A supervised analysis of gene-expression profiles of purified clonal plasma cells from patients with systemic light-chain amyloidosis (AL) who have high or low levels of serum free lambda light chains

Book Section

Comenzo, R. L.; Zhou, P.; Fleisher, M.; Olshen, A. B.
In Skinner, M.; Berk, J. L.; Connors, L. H.; Seldin, D. C. (Eds.) XIth International Symposium on Amyloidosis (2008)

Fulltext@MSK | Save

Risk-adapted melphalan with stem cell transplant (SCT) and adjuvant dexamethasone (dex) +/- thalidomide (thal) achieves low treatment related mortality and high hematologic response rates

Book Section

Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Clark, B.; Stubblefield, M.; Fleisher, M.; Nimer, S. D.; more...
In Skinner, M.; Berk, J. L.; Connors, L. H.; Seldin, D. C. (Eds.) XIth International Symposium on Amyloidosis (2008)

Fulltext@MSK | Save

CD32B expression reflects phenotypic and functional heterogeneity in multiple myeloma (MM)

Meeting Abstract

Zhou, P.; Boruchov, A. M.; Hoffman, J. E.; Mo, Q. X.; Olshen, A.; Glasner, E.; Bonvini, E.; Koenig, S.; Drieghe, E.; Fleisher, M.; more...
Blood (2008)

Fulltext@MSK | Save

Phase I-II study of MDV3100 in castration resistant prostate cancer. The Prostate Cancer Clinical Trials consortium

Meeting Abstract

Scher, H.; Beer, T.; Higano, C.; Logothetis, C.; Shelkey, J.; Hung, D.; Hirmand, M.; Larson, S.; Fleisher, M.; Sawyers, C.
EJC Supplements (2008)

Fulltext@MSK | Save

Pralatrexate (PDX) produces a high and durable complete response rate in patients with chemotherapy resistant T-cell lymphomas

Meeting Abstract

O'Connor, O. A.; Hamlin, P.; Moskowitz, C.; Portlock, C.; Sarasohn, D.; Dumitrescu, O.; Neylon, E.; Patterson, M.; Zelenetz, A.; Saunders, M.; more...
Annals of Oncology (2008)

Fulltext@MSK | Save

Ykl-40 and matrix metalloproteinase-9 (Mmp-9) as serum tumor markers in gliomas

Meeting Abstract

Iwamoto, F.; Hottinger, A.; Jahdi, M.; Dantis, J.; Karimi, S.; Riedel, E.; Panageas, K.; Gu, B.; Rao, J.; Fleisher, M.; more...
Neuro-Oncology (2008)

Fulltext@MSK | Save

CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy

Journal Article

Zhou, P.; Comenzo, R. L.; Olshen, A. B.; Bonvini, E.; Koenig, S.; Maslak, P. G.; Fleisher, M.; Hoffman, J.; Jhanwar, S.; Young, J. W.; more...
Blood (2008)

Fulltext@MSK | Save

Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan

Journal Article

Zhou, P.; Teruya-Feldstein, J.; Lu, P.; Fleisher, M.; Olshen, A.; Comenzo, R. L.
Blood (2008)

Fulltext@MSK | Save

Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal

Journal Article

Tuttle, R. M.; Brokhin, M.; Omry, G.; Martorella, A. J.; Larson, S. M.; Grewal, R. K.; Fleisher, M.; Robbins, R. J.
Journal of Nuclear Medicine (2008)

Fulltext@MSK | Save

Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer

Journal Article

Rathkopf, D.; Carducci, M. A.; Morris, M. J.; Slovin, S. F.; Eisenberger, M. A.; Pili, R.; Denmeade, S. R.; Kelsen, M.; Curley, T.; Halter, M.; more...
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save